Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (251)	12/9/2005 10:02:05 PM
From: Jibacoa	Read Replies (1) of 684

Mike, As you said, DPII certainly looks cheap. Yahoo lists its cash/shr at $3.05 its Debt/Equt at 0.002and BV at $3.94 It also shows a positive CF of $6.88M & +FCF of $1.33M finance.yahoo.com IBD lists it at 0.57 of BV with a + CF of $0.41 One problem is that revenues have been down 16% on each of the last 3Qs and the loss for the 9 months is now $0.18/shr with an EL for 2005 of $0.35/shr. If this last item is correct, it means that the pending 4thQ should show a loss of $0.17/shr, which won't compare well with the last Q in 2004 when earnings were $0.05/shr on the black column. For 2006 the EL is still $0.29/shr. Will see if the changes made on the BOD last month will make some positive changes.<g> (Riccardo Pigliucci resigned & Michael Venuti is now the interim CEO with Harry Hixson as Chairman.) I will keep DPII on a watch list. It seems to show some suppport at the 2.25 level and resistance now at 2.45 It may have reached the lowest level for a while, but I am not anxious of buying any and would rather wait for it to go back above the $3 or even the $3.50 level RAGL Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next